The protective role of antibodies in cryptococcal infection is questionable. Several workers were unable to protect experimental animals from a challenge infection with Cryptococcus neoformans after passively transferring cryptococcal antibodies (3, 10, 11, 17) . However, there are other reports where passive transfer of antibodies increased the survival time of infected animals (8, 9) . Recently, antibody-dependent killing of C. neofornans by human peripheral blood mononuclear cells has been demonstrated (2, 4) . In human disseminated cases of cryptococcosis, antibodies are often absent or are present only in very low titers (1) .
Our earlier study on cryptococcal infection in thymectomized animals Midicated that antibodies alone did not influence the course of infection (unpublished observations). The present study was undertaken to investigate the role of antibodies in experimental cryptococcosis in mice by using normal and B-cell-deficient animals. (16) . However, Gade- busch (8), and Gadebusch and Gikas (9) claimed that passive antibody transfer protected against a lethal C. neoformans challenge. The protection was, however, limited to the period of immunization and was type specific. As immune serum and challenge dose were given intraperitoneally within 2 h of each other, it appears likely that immune serum eliminated the organisms by agglutination before they had a chance to attack the host. Diamond (2) reported that human peripheral blood leukocytes in the presence of specific antibody could kill C. neoformans by a nonphagocytic mechanism. It was further observed that nonphagocytic lymphoid cells (lymphocytes) had this fungicidal capacity (4) . But no such activity by these cells was seen in the presence of normal serum (2) . The present study suggests that such an in vitro phenomenon may not have The presence of cryptococcal antibody in the sera of patients with cryptococcosis has been correlated with a favorable prognosis (5, 24) . The presence of antibodies, however, may not be directly influencing the course of infection. A lesser amount of free antigen in milder disease, not sufficient to neutralize the antibodies, would account for their presence being correlated with a good prognosis. Development of disseminated cryptococcosis in humans is usually associated with abnormalities in cell-mediated immune responses (6, 7, 12, 22) .
Graybill and Mitchell (13) did not find any difference in mortality patterns of normal and cyclophosphamide-treated mice after challenge with C. neoformans unless very high doses of cyclophosphamide were administered. Cyclophosphamide is known to have a predominant effect on B lymphocytes in mice (23 
